RG-101

Regulus reports a trio of pipeline setbacks
BioPharma Dive
Tue, 06/13/17 - 12:00 pm
Regulus
RG-101
RGLS5040
RG-105
cholestatic disease
type 2 diabetes
hepatitis C
Regulus Hep C Drug Stays On Clinical Hold
Investopedia
Wed, 02/1/17 - 09:37 am
Regulus
hepatitis C
RG-101
Regulus hits further setbacks as clinical hold upheld
BioPharma Dive
Mon, 01/30/17 - 11:40 am
Regulus
clinical trials
RG-101
hepatitis C
FDA halts testing of Regulus' Hep C drug, sending shares into tailspin
BioPharma Dive
Tue, 06/28/16 - 11:04 am
FDA
Regulus
hepatitis C
clinical trials
RG-101
Should Gilead Investors Fear Regulus?
Seeking Alpha
Thu, 02/18/16 - 09:37 am
Gilead Sciences
Regulus
hepatitis C
Harvoni
RG-101
Regulus Bolsters Argument for Effective Hepatitis C Injection
TheStreet.com
Wed, 02/17/16 - 11:36 am
Regulus
hepatitis C
RG-101
3 Key FDA Decisions Expected in February
24/7 Wall St
Sun, 01/31/16 - 01:38 pm
FDA
Vertex Pharmaceuticals
Kalydeco
Regulus
RG-101
Sarepta Therapeutics
eteplirsen
Regulus slides after hep C contender's results underwhelm investors
Fierce Biotech
Mon, 02/9/15 - 08:30 am
Regulus
hepatitis C
RG-101
microRNA
How 1 Tiny Hepatitis C Drug Developer Trounced Gilead Sciences, Inc. in 2014
Motley Fool
Fri, 01/2/15 - 08:26 am
hepatitis C
Gilead Sciences
Regulus
Harvoni
Sovaldi
RG-101
Regulus Therapeutics more than doubles on early data for microRNA treatment for hepatitis C
Yahoo/AP
Wed, 10/22/14 - 07:05 pm
Regulus
hepatitis C
microRNA
RG-101